Is DANAHER CORP /DE/ (DHR) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 14.2% / 30% | 3.3% / 30% | 2.8% / 30% | 0.12% / 5% | ✓ HALAL |
| DJIM | 14.2% / 33% | 3.3% / 33% | 2.8% / 33% | 0.12% / 5% | ✓ HALAL |
| MSCI | 23.6% / 33% | 5.5% / 33% | 4.7% / 33% | 0.12% / 5% | ✓ HALAL |
| S&P | 14.2% / 33% | 3.3% / 33% | 2.8% / 33% | 0.12% / 5% | ✓ HALAL |
| FTSE | 23.6% / 33% | 5.5% / 33% | 4.7% / 50% | 0.12% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 59.2% | |
| Operating Margin | 22.2% | |
| Net Margin | 14.7% | |
| Return on Equity (ROE) | 7.1% | |
| Return on Assets (ROA) | 4.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $6.4B |
| Free Cash Flow | $5.3B |
| Total Debt | $19.7B |
| Debt-to-Equity | 37.5 |
| Current Ratio | 1.9 |
| Total Assets | $83.5B |
Price & Trading
| Last Close | $187.65 |
| 50-Day MA | $209.87 |
| 200-Day MA | $210.06 |
| Avg Volume | 3.9M |
| Beta | 1.0 |
|
52-Week Range
$171.00
| |
About DANAHER CORP /DE/ (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Purification Calculator
As a halal stock with 0.12% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is DANAHER CORP /DE/ (DHR) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), DANAHER CORP /DE/ is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is DANAHER CORP /DE/'s debt ratio?
DANAHER CORP /DE/'s debt ratio is 14.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 23.6%.
Does DANAHER CORP /DE/ require dividend purification?
Yes, DANAHER CORP /DE/ has an impermissible income ratio of 0.12%, which means 0.12% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are DANAHER CORP /DE/'s key financial metrics?
DANAHER CORP /DE/ has a market capitalization of $128.5B, trailing P/E ratio of 36.1, and revenue of $24.6B. The company maintains a gross margin of 59.2% and a net margin of 14.7%. Return on equity stands at 7.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.